✦ LIBER ✦

Correlation of PSA with long term outcome in patients treated for prostatic carcinoma

✍ Scribed by Michael J. Zelefsky; Willet F. Whitmore; Steven A. Leibel; Zvi Fuks

Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 200 KB
Volume: 27
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(93)90736-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pre-treatment psa as a predictor of long

Pre-treatment psa as a predictor of long-term outcome in patients definitively irradiated for prostatic carcinoma

✍ A. Kuban Deborah; M. El-Mahdi Anas; F. Schellhammer Paul 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Impact of transurethral resection on the

Impact of transurethral resection on the long term outcome in patients with prostatic carcinoma

✍ Michael J. Zelefsky; Willet F. Whitmore Jr.; Steven A. Leibel; Kent E. Wallner; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Long-term outcomes for patients with sol

Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulation

✍ Chiaki Kawamoto; Kenichi Ido; Norio Isoda; Masanori Hozumi; Nobuhiko Nagamine; K 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Long-term outcome of radical radiation t

Long-term outcome of radical radiation therapy for prostatic carcinoma: 1967–1987

✍ Per Hahn; Edward Baral; Mary Cheang; Jeri Kostyra; Randall Roelss 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 1020 KB

Long term outcome of patients with hairy

Long term outcome of patients with hairy cell leukemia treated with pentostatin

✍ Patricia Ribeiro; Fadhela Bouaffia; Pierre-Yves Peaud; Michel Blanc; Bruno Salle 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

## BACKGROUND. With the introduction of new drugs such as interferon-␣ (IFN) and purine analogs, the management of hairy cell leukemia (HCL) patients has changed. However, pentostatin has been found to produce higher complete remission rates than IFN. The current study was undertaken to investigat

Long-term outcome of patients with monos

Long-term outcome of patients with monostotic Ewing's sarcoma treated with combined modality

✍ Gasparini, Marco ;Lombardi, Fabrizio ;Ballerini, Emanuela ;Gandola, Lorenza ;Gia 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 627 KB

## Abstract One hundred and twenty‐one consecutive patients with monostotic Ewing's sarcoma (ES) were treated according to three consecutive combined modality programs from 1974 to 1986. Their 3‐year progression free survival (PFS) rate from diagnosis of 59% was identical to the event free survival